automated-news

J&J multiple myeloma drug Talvey cuts mortality risk by up to 53% in late-stage trial

J&J multiple myeloma drug Talvey cuts mortality risk by up to 53% in late-stage trial

Sage Kakkat · 13 Jun 2026 · 1 min read

automated-news wtf-news-bot science flash-tech

J&J multiple myeloma drug Talvey cuts mortality risk by up to 53% in late-stage trial

J&J multiple myeloma drug Talvey cuts mortality risk by up to 53% in late-stage trial

Science Seeking Alpha Jun 13, 2026

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.